Results 351 to 360 of about 580,532 (393)
Some of the next articles are maybe not open access.

Alcoholic dilated cardiomyopathy

Nursing Standard, 2008
This article provides an overview of alcoholic dilated cardiomyopathy. It aims to increase awareness of the condition among nurses, and help in early diagnosis and appropriate treatment referrals. The key message is that all patients with alcoholic dilated cardiomyopathy should be advised and assisted to stop drinking alcohol.
Christopher Nicholson   +2 more
openaire   +3 more sources

Dilated cardiomyopathy: a review

Journal of Clinical Pathology, 2008
Dilated cardiomyopathy (DCM) is a common cardiac diagnosis that may result as a consequence of a variety of pathologies. The differential diagnosis remains quite broad since many pathologies can present as DCM, and as a result the approach to diagnosis may, at times, be quite difficult.
Eric Ahn   +3 more
openaire   +3 more sources

Genetics in Dilated Cardiomyopathy

Biomarkers in Medicine, 2013
Discoveries made during the last 20 years have revealed a genetic origin in many cases of dilated cardiomyopathy (DCM). Currently, over 40 genes have been associated with the disease. Mutations in DCM-causing genes induce the condition through a variety of different pathological pathways with complex and not completely understood mechanisms. Genes that
Luis Alonso-Pulpón   +7 more
openaire   +3 more sources

Dilated cardiomyopathy in children

Acta Paediatrica, 2006
AbstractDilated cardiomyopathy (DCM) is a rare disease in the paediatric population. We analysed the epidemiology, clinical features and role of immunotherapy in the treatment of myocarditis. On the basis of experimental evidence, indicating that autoimmunity might play a role in the development of myocarditis, we treated children affected by ...
openaire   +4 more sources

Familial dilated cardiomyopathy

American Journal of Medical Genetics, 1988
AbstractIdiopathic dilated cardiomyopathy is generally considered a sporadic, nongenetic disorder, and reports of familial cases are often regarded as rare occurrences. Results of the present investigation of 6 families with this disorder suggest that familial forms of dilated cardiomyopathy occur more frequently than previously suspected. The familial
Michael A. Schmidt   +5 more
openaire   +3 more sources

Genetics of Dilated Cardiomyopathy

Heart Failure Clinics, 2010
Dilated cardiomyopathy (DCM) is a myocardial disorder defined by ventricular chamber enlargement and systolic dysfunction. DCM can result in progressive heart failure, arrhythmias, thromboembolism, and premature death, and contributes significantly to health care costs. In many cases, DCM results from acquired factors that affect cardiomyocyte function
Diane Fatkin   +4 more
openaire   +3 more sources

Pharmacotherapy of Dilated Cardiomyopathy

Current Pharmaceutical Design, 2014
The pharmacological treatment of dilated cardiomyopathy overlaps with the treatment of heart failure. The primary objective of this treatment is to slow the progression of disease and improve quality and length of life. All patients, including those with asymptomatic dysfunction of the left ventricle, ought to receive angiotensin converting enzyme ...
Jindřich Špinar, Lenka Špinarová
openaire   +3 more sources

Immunoadsorption in Dilated Cardiomyopathy

Therapeutic Apheresis, 2000
Abstract: The prognosis for patients suffering from advanced stages of dilated cardiomyopathy (DCM) is poor. Recent studies have shown that immunoadsorption (IA) may represent an effective alternative therapeutic approach for other kinds of autoimmune diseases with circulating autoantibodies. The objective of this pilot study was to ascertain the short‐
Gert Baumann   +3 more
openaire   +3 more sources

ALCOHOL AND DILATED CARDIOMYOPATHY

Alcohol and Alcoholism, 1986
Alcohol has been considered a cardiotoxin for over a century, but the pathogenesis and natural history of alcohol-related heart disease remains obscure. The diagnosis still rests on the coincidence of alcoholism and a dilated hypocontractile heart in the absence of any other cause of dilated cardiomyopathy.
Mark Dancy, J. D. Maxwell
openaire   +3 more sources

Anaphylatoxins in dilated cardiomyopathy

Journal of Internal Medicine, 1993
Abstract. Objects. The aim of the study was to investigate the possible relationship between activation of complement system and thromboembolic complications in dilated cardiomyopathy (DCMP).Methods. The plasma C3a and C5a concentrations were determined by radioimmunoassay measurement (Amersham International, UK) in 23 patients with DCMP, 9 with ...
E.L. Nassonov   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy